JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 47:1919-1926, doi:10.1016/j.jacc.2005.12.067 (Published online 21 April 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gelfand, E. V.
Right arrow Articles by Cannon, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelfand, E. V.
Right arrow Articles by Cannon, C. P.

Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors

Eli V. Gelfand, MD* and Christopher P. Cannon, MD{dagger},a,*

* Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
{dagger} TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts


Figure 1
View larger version (28K):

[in a new window]
  		Figure 1 Change in body weight among subjects in the Rimonabant in Obesity (RIO)-Lipids study. Reprinted, with permission, from Despres et al. (62).

 

Figure 2
View larger version (12K):

[in a new window]
  		Figure 2 Percentage of subjects achieving ≥10% weight loss at one year with rimonabant (solid bars) 20 mg/day versus placebo (open bars) in the first two Rimonabant in Obesity (RIO) trials among those completing the study.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.